CClinicalTrials.gg
CompletedNCT07478965Updated Mar 23, 2026

Effects of Acupuncture Versus Deep Breathing Exercises on Hypertensive Pregnant Women in the Third Trimester

An interventional study of Acupuncture and Deep breathing exercise in Hypertension ,Pregnancy, sponsored by October 6 University. Completed at 1 site in Egypt. Open to female participants aged 25 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-03-23.

Sponsored by October 6 University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Aug 2025, registered Mar 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
25 Years to 35 Years
Sex
Female
01

Study summary

investigate the effect of diaphragmatic deep breathing exercises versus acupuncture hypertensive adults This study is expected to provide significant health benefits for pregnant females in the third trimester suffering from hypertension.

Read the detailed description

The study contributes to lowering the risk of hypertension complications in the pregnant women in the third trimester through a study investigate the effect of diaphragmatic deep breathing exercises versus acupuncture on prehypertensive or hypertensive adults

02

Conditions studied

  • Hypertension ,Pregnancy

Keywords

  • Acupuncture
  • Deep breathing exercise
  • Hypertension
  • Third trimester
03

In context

Hypertension, Pregnancy-Induced

240 studies on the registry are indexed under Hypertension, Pregnancy-Induced; 66 are open to participants now.

This study's enrollment of 40 is below the median of 144 across 163 interventional studies indexed under Hypertension, Pregnancy-Induced.

Browse Hypertension, Pregnancy-Induced studies →

Lead sponsor

October 6 University is the lead sponsor of 135 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • pregnant women in the third trimester
  • suffering from hypertension
  • age ranged between 25-35

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled diabetes
  • Rhumatoid arthritis
  • Any respiratory disease like athma
  • osteoporosis
  • Any kind of infection
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double (Participant, Investigator)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Acupuncture Group: 20pregnant women received it.

    Study group 1: composed of 20 pregnant women received physical therapy session of acupuncture

    Device: Acupuncture

  • Experimental
    Deep breathing Group:20pregnant women received it.

    Study group 2: composed of 20 pregnant women received physical therapy session received Deep breathing exercise

    Other: Deep breathing exercise

Interventions

  • DeviceAcupuncture

    traditional Chinese medicine practice that involves inserting fine needles into specific points on the body to promote healing and balance.

  • OtherDeep breathing exercise

    Deep breathing exercises can significantly reduce stress and anxiety, improve focus, and enhance overall well-being.

06

What researchers measure

Primary outcomes

  1. Blood pressure

    A sphygmomanometer is an instrument used to measure blood pressure. Normally value ranged from 100-140 on systole and 60-90 on diastole An inflatable cuff that wraps around the upper arm. A measuring unit, which can be a mercury manometer or an aneroid gauge, that records the pressure.

    Time frame: 2 weeks

07

Study locations

1 site
  • Kerolous Ishak Shehata Kelini
    Cairo, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07478965
Lead sponsor
October 6 University
Responsible party
Kerolous Ishak Shehata (lecturer, October 6 University) — Principal investigator
First posted
Mar 18, 2026
Start date
Aug 27, 2025
Primary completion
Nov 11, 2025
Completion
Jan 20, 2026
Last update
Mar 23, 2026

Study contacts

Kerolous IS Kelini
principal investigator · Al-Zaytoonah University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion